Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02756247
Title A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

Buparlisib + Ibrutinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.